Survival of persons with and without HIV infection in Denmark, 1995-2005.
about
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsComplementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV careLife expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studiesThe cost-effectiveness of Vancouver's supervised injection facilityNatural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic InfectionA systematic review of effects of concurrent strength and endurance training on the health-related quality of life and cardiopulmonary status in patients with HIV/AIDST-cell aging in rheumatoid arthritisOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationScreening for chronic comorbid diseases in people with HIV: the need for a strategic approachAssociation of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisEpidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patientsIdentification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.Understanding HIV latency: the road to an HIV cureStrengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaborationImpact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort studyInflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort studyFrailty, HIV infection, and mortality in an aging cohort of injection drug usersThe clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefitIllicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in TokyoHIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gapsEvaluation of a HIV voluntary opt-out screening program in a Singapore hospitalThe burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapyAssociation of Cardiometabolic Multimorbidity With MortalityA Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trialThe CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recoveryDermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationCardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events ofLung cancer in HIV patients and their parents: a Danish cohort study.Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapyRetrivability in The Danish National Hospital Registry of HIV and hepatitis B and C coinfection diagnoses of patients managed in HIV centers 1995-2004.Taking on the challenge of noncommunicable diseases: we all hold a piece of the puzzle.Associations of HIV testing and late diagnosis at a Japanese university hospitalMortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort studyThe effect of combined antiretroviral therapy on the overall mortality of HIV-infected individualsAssociation of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.Contribution of intestinal barrier damage, microbial translocation and HIV-1 infection status to an inflammaging signatureRisk of myocardial infarction in parents of HIV-infected Individuals: a population-based Cohort Study.HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
P2860
Q21562140-B1E7F781-432E-4A66-A88A-A5E4D2414EFBQ22248035-9D752D12-DA5A-458D-9309-09B17441D724Q24597052-782FAD72-BBFA-4956-A0CE-E330F0E18576Q24657903-62B4CDEB-3093-4843-88D8-FE43CBBBC0E2Q26775036-DDA138F5-CE7D-45A6-809C-A73337ACCD26Q26821799-E0B2A241-A6FD-4100-92C7-E906828B265BQ26859971-1B4005B1-D94B-48F2-B587-2838F8EAC5BAQ26864478-4E654AA9-9F56-4B0A-8AF4-5B4F1D5E9FBEQ26866452-E328B62E-08C5-4E50-BEAD-70F779D96A0AQ27000959-C82032B0-7F6A-4F16-8164-37A66E1947D7Q27009523-E1440567-A2F2-4724-9037-9651A127AE77Q27318276-D5FF2454-96C4-43A3-AA0B-0DD76B92DB6FQ28085296-D39C77F4-00AC-45E1-9BED-FD243FEC8C08Q28222847-1660D25C-969E-4ABE-BF57-4DBE04799154Q28479266-7A3D14F2-A88F-4F87-81C9-E0D60EC2CD13Q28484274-CADDFBA3-A08C-49FA-AF94-67ECB038D5C9Q28485898-7B8574C3-52B5-42F8-ACDB-681027F5DC32Q28535156-D09EB0D5-7CE2-4184-A6C9-9C9716FC3B4CQ28535181-1B38818E-FBDE-4218-8DD7-8A1974D800F6Q28535365-6891D31E-0940-4C90-A9FC-5C7142189741Q28543053-C9B02B43-8414-4D08-8565-90EF37D4459DQ28544453-7BAB3B31-6895-4620-A781-A7602F765091Q28606934-C9DDB2EE-6704-488B-9797-11971940059CQ28647861-1D963BB8-BC94-47A4-968E-0F2843243C6CQ28730855-1DBBA278-0A6E-495B-A44B-80CDDEB89DBBQ29307877-EACF9BDA-B6AE-4913-980E-753DAC2E410CQ30408029-97DD677F-B952-4900-8D34-B68BBE0BE464Q30839904-1ECF4961-8CD2-4967-AE0C-98E944B23E34Q30987054-F742B9A9-5C83-42D6-B446-769FD7FA1972Q31021219-C1229350-1FC8-4255-B713-BACAE6203240Q31106702-B1D5AFA0-B727-4395-AF11-F35A1E85953CQ33330995-298763FA-D366-43F5-B0A1-CD0798DACFADQ33352562-965C1FF2-69DE-4762-9A17-0F2FAE3AC535Q33430425-6539FBCA-4CA7-459C-8C52-EC4093268FC1Q33502708-5CC509AB-6F9C-4605-A0EC-D9057C30BFEBQ33505475-9228FB29-5B4F-4474-B4A3-CA58CCFD1868Q33563357-B378A894-2C42-4E6A-B1DC-FF762B7473D7Q33599291-FE1C8291-6176-4045-9F10-B1159114F4BFQ33603728-947CD3F7-C5B9-4419-B053-C8FE83EF6076Q33618542-81106EBE-E8CE-4E26-820D-58725A414835
P2860
Survival of persons with and without HIV infection in Denmark, 1995-2005.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@en
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@nl
type
label
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@en
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@nl
prefLabel
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@en
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@nl
P2093
P1476
Survival of persons with and without HIV infection in Denmark, 1995-2005.
@en
P2093
Ann-Brit Eg Hansen
Gitte Kronborg
Gitte Pedersen
Jan Gerstoft
Michael Vaeth
Nicolai Lohse
P356
10.7326/0003-4819-146-2-200701160-00003
P407
P577
2007-01-01T00:00:00Z